Abstract
Introduction. Sleep disorders in Parkinson's disease are present in 60-98% of patients and reduce their quality of life.
Aims. To review the pathophysiology, diagnostic approach and management of the different sleep disorders.
Development. We describe the pathophysiology associated with neurodegeneration, due to symptoms (motor and nonmotor) and drug therapies. This article reviews insomnia, excessive daytime sleepiness, circadian sleep disorders and sleep apnea.
Conclusions. Subjective or objective sleepiness assessment should routinely be performed by physicians looking after Parkinson's disease patients. Management is difficult and should be targeted to the specific sleep disorder and its likely cause.